Janel Acquires EnCor Biotechnology for $17 Million
Janel paid $11.96 million in cash and issued a $5.04 million subordinated note. It also increased acquisition facility commitments by $15 million, with $11 million funded for the acquisition.
Janel acquired EnCor Biotechnology for $17 million, comprising $11.96 million in cash and a $5.04 million subordinated note. To help fund the transaction, Janel amended its senior credit agreement, increasing acquisition facility commitments by $15 million; $11 million was funded for the acquisitio…